What actually happens inside a dog's adrenal glands when a tumor forms?

Each adrenal gland has two functionally distinct parts: an outer cortex that makes steroid hormones like cortisol and aldosterone, and an inner medulla that produces the stress hormones epinephrine and norepinephrine. A tumor can arise from either region, and roughly half of all adrenal masses found in dogs are functional, meaning they actively secrete excess hormone rather than sitting inert (Cornell Riney Canine Health Center, 2023). Cortex tumors that overproduce cortisol are a leading cause of Cushing's syndrome in dogs, while medulla tumors called pheochromocytomas flood the bloodstream with catecholamines that spike heart rate and blood pressure.

Adrenal tumors are broadly split into adenomas, which are benign, and adenocarcinomas, which are malignant and can invade the adjacent vena cava or spread to the liver and lungs. The American College of Veterinary Internal Medicine notes that up to 50% of adrenal masses identified on abdominal imaging in dogs turn out to be malignant carcinomas rather than benign adenomas, which is why size and imaging characteristics matter as much as hormone testing (ACVIM, 2020). Pheochromocytomas, though less common than cortical tumors, are considered malignant in behavior in a substantial proportion of cases even when they look small on a scan.

What symptoms make an owner first suspect something is wrong?

Owners of dogs with a cortisol-secreting adrenal tumor typically notice a cluster of changes over weeks to months: increased thirst and urination, a ravenous appetite, thinning fur along the flanks, and a bloated, pot-bellied abdomen caused by weakened muscle and fat redistribution. These are the same signs seen in classic pituitary-dependent Cushing's disease, since roughly 15-20% of Cushing's cases in dogs originate from an adrenal tumor rather than the pituitary gland (Merck Veterinary Manual, 2023).

When the tumor instead involves the adrenal medulla, the pattern looks different and can be far more abrupt: episodic panting, weakness, collapse, or a racing heart rate that comes and goes, sometimes triggered by abdominal palpation or stress. Because pheochromocytomas can intermittently release large amounts of adrenaline, some dogs present with sudden collapse or even acute abdominal bleeding if the tumor ruptures, which veterinary emergency literature describes as a recognized complication requiring immediate stabilization (Cornell Riney Canine Health Center, 2023).

What causes adrenal tumors, and which dogs are most at risk?

The precise cause of most canine adrenal tumors isn't known, but age is the strongest predictor: these masses are most often diagnosed in dogs older than 8 years, with no single breed spared, though larger and mixed-breed dogs are frequently represented in case series (Merck Veterinary Manual, 2023). Unlike pituitary-dependent Cushing's, which shows some predisposition in Poodles, Dachshunds, and terrier breeds, adrenal-based tumors appear more sporadically distributed across breeds and sexes.

There is no established environmental or dietary trigger, and genetic studies in dogs have not identified a clear inherited mutation the way some human adrenal cancer syndromes have. What is established is that incidental adrenal masses are being found more often simply because abdominal ultrasound is used more routinely; some retrospective studies estimate incidental adrenal nodules turn up in roughly 1 in 200 dogs undergoing abdominal imaging for unrelated reasons, and many of these are never hormonally active (ACVIM, 2020).

How do veterinarians confirm an adrenal tumor rather than another condition?

Diagnosis starts with bloodwork and urine testing to look for the metabolic footprint of excess cortisol, such as elevated liver enzymes, dilute urine, and an elevated cortisol-to-creatinine ratio, followed by a low-dose dexamethasone suppression test or ACTH stimulation test to confirm Cushing's syndrome and help distinguish an adrenal source from a pituitary one (Merck Veterinary Manual, 2023). None of these blood tests can see the tumor itself, so imaging is essential.

Abdominal ultrasound is the first-line imaging tool for visualizing the adrenal glands and typically can detect masses larger than about 2 cm, while also screening for invasion into the nearby vena cava, a finding that significantly changes the surgical plan. When surgery is being considered or vena cava invasion is suspected, veterinary internists commonly recommend a CT scan for a more precise map of the tumor's borders and blood supply, since the Cornell Riney Canine Health Center notes that pre-surgical CT substantially improves outcomes by allowing surgeons to anticipate vascular involvement before making the first incision (Cornell Riney Canine Health Center, 2023).

Is surgery always necessary, or can medication manage the tumor instead?

Adrenalectomy, surgical removal of the affected gland, is considered the treatment of choice for adrenal tumors without evidence of widespread metastasis, and reported perioperative survival rates in specialty surgical centers run around 80-90% when the tumor has not invaded the vena cava, though risk rises considerably with vascular involvement (ACVIM, 2020). This is major abdominal surgery best performed at a referral hospital with 24-hour monitoring, since intraoperative hemorrhage and blood pressure swings are recognized risks, particularly with pheochromocytomas.

For dogs that are poor surgical candidates due to age, other illness, or tumor size, medical management with drugs such as trilostane or mitotane can control the hormonal effects of a cortisol-secreting tumor, though these medications manage symptoms rather than shrink or cure the tumor itself. Dogs on trilostane require repeat ACTH stimulation testing, often starting at 10-14 days after beginning treatment, to fine-tune dosing and avoid dangerously low cortisol levels (Merck Veterinary Manual, 2023).

What does day-to-day home care look like after diagnosis or surgery?

Dogs recovering from adrenalectomy need strict activity restriction for roughly 2 weeks to protect the incision and reduce the risk of internal bleeding, along with close monitoring for lethargy, vomiting, or a distended abdomen that could signal a post-surgical complication. Dogs managed medically instead of surgically need scheduled rechecks, typically starting a few weeks after any dose adjustment and then continuing every 3-6 months, to catch electrolyte imbalances or Addisonian crises before they become emergencies (Merck Veterinary Manual, 2023).

Owners managing a dog long-term on trilostane or mitotane should keep a simple daily log of water intake, appetite, and energy level, because subtle changes are often the earliest clue that a dose needs adjusting. Feeding a consistent, moderate-fat diet also helps because dogs with any degree of adrenal dysfunction are prone to pancreatitis, and sudden fatty treats or table scraps can trigger a flare (Cornell Riney Canine Health Center, 2023).

What is the realistic long-term outlook for a dog with this diagnosis?

Prognosis depends heavily on tumor type and whether it has invaded the vena cava or spread. Dogs with a benign adenoma that is fully removed can have a normal life expectancy, while median survival times reported for dogs with adrenal carcinoma after successful surgery commonly fall in the range of 1 to 3 years, compared to just a few months for dogs managed with medication alone once metastasis is present (ACVIM, 2020). Pheochromocytomas that are surgically removed before rupture also carry a meaningfully better prognosis than those diagnosed only after a bleeding crisis.

For dogs whose owners choose medical management over surgery, quality of life can often be maintained for a year or more with regular monitoring, though the underlying tumor is still present and can eventually grow or metastasize. Because so much of the outcome hinges on catching the tumor before vena cava invasion occurs, veterinary oncologists increasingly recommend that any incidental adrenal mass found on a senior dog's routine ultrasound be rechecked within a few months rather than dismissed, even if it isn't hormonally active yet (Cornell Riney Canine Health Center, 2023).